Antihemophilic Factor (Recombinant [Porcine Sequence]) and Larotrectinib Oral Solution
Determining the interaction of Antihemophilic Factor (Recombinant [Porcine Sequence]) and Larotrectinib Oral Solution and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant [Porcine Sequence])-Larotrectinib Sulfate
- Antihemophilic Factor (Recombinant [Porcine Sequence])-Lartruvo
- Antihemophilic Factor (Recombinant [Porcine Sequence])-Larynex
- Antihemophilic Factor (Recombinant [Porcine Sequence])-Laryng-O-Jet
- Antihemophilic Factor (Recombinant [Porcine Sequence])-Laryngesic
- Antihemophilic Factor (Recombinant [Porcine Sequence])-Lasix
- Larotrectinib Oral Solution-Antihemophilic Factor (Recombinant) (Advate)
- Larotrectinib Oral Solution-Antihemophilic Factor (Recombinant) (Afstyla)
- Larotrectinib Oral Solution-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Larotrectinib Oral Solution-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)
- Larotrectinib Oral Solution-Antihemophilic Factor (Recombinant) (Nuwiq)
- Larotrectinib Oral Solution-Antihemophilic Factor (Recombinant) (Recombinate)